GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 36.55
-0.65 (-1.75%)
Mar 26, 2026, 1:08 PM CST
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.52 billion as of March 26, 2026. Its market cap has decreased by -35.31% in one year.
Market Cap
1.52B
Enterprise Value
1.56B
Revenue
677.10M
Ranking
n/a
PE Ratio
52.21
Stock Price
36.55
Market Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.52B, a decrease of -30.30%. That is a compound annual growth rate of -3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 1.52B | -24.25% |
| Dec 31, 2025 | 2.00B | 2.66% |
| Dec 31, 2024 | 1.95B | -36.91% |
| Dec 29, 2023 | 3.09B | 11.36% |
| Dec 30, 2022 | 2.77B | 53.32% |
| Dec 30, 2021 | 1.81B | 122.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.97B |
| Tien Liang BioTech | 1.62B |
| InnoPharmax | 1.55B |
| Winston Medical Supply | 1.30B |
| DV Biomed | 1.29B |
| Excelsior Biopharma | 1.23B |
| Anxo Pharmaceutical | 1.09B |
| Mediera | 1.03B |